Literature DB >> 23182931

Travel-associated sexually transmitted infections: an observational cross-sectional study of the GeoSentinel surveillance database.

Alberto Matteelli1, Patricia Schlagenhauf, Anna Cc Carvalho, Leisa Weld, Xiaohong M Davis, Annelies Wilder-Smith, Elizabeth D Barnett, Philippe Parola, Prativa Pandey, Pauline Han, Francesco Castelli.   

Abstract

BACKGROUND: Travel is thought to be a risk factor for the acquisition of sexually transmitted infections (STIs), but no multicentre analyses have been done. We aimed to describe the range of diseases and the demographic and geographical factors associated with the acquisition of travel-related STIs through analysis of the data gathered by GeoSentinel travel medicine clinics worldwide.
METHODS: We gathered data from ill travellers visiting GeoSentinel clinics worldwide between June 1, 1996, and Nov 30, 2010, and analysed them to identify STIs in three clinical settings: after travel, during travel, or immigration travel. We calculated proportionate morbidity for each of the three traveller groups and did logistic regression to assess the association between STIs and demographic, geographical, and travel variables.
FINDINGS: Our final analysis was of 112 180 ill travellers-64 335 patients seen after travel, 38 287 patients seen during travel, and 9558 immigrant patients. 974 patients (0·9%) had diagnoses of STIs, and 1001 STIs were diagnosed. The proportionate STI morbidities were 6·6, 10·2, and 16·8 per 1000 travellers in the three groups, respectively. STIs varied substantially according to the traveller category. The most common STI diagnoses were non-gonococcal or unspecified urethritis (30·2%) and acute HIV infection (27·6%) in patients seen after travel; non-gonococcal or unspecified urethritis (21·1%), epididymitis (15·2%), and cervicitis (12·3%) in patients seen during travel; and syphilis in immigrant travellers (67·8%). In ill travellers seen after travel, significant associations were noted between diagnosis of STIs and male sex, travelling to visit friends or relatives, travel duration of less than 1 month, and not having pretravel health consultations.
INTERPRETATION: The range of STIs varies substantially according to traveller category. STI preventive strategies should be particularly targeted at men and travellers visiting friends or relatives. Our data suggest target groups for pretravel interventions and should assist in post-travel screening and decision making. FUNDING: US Centers for Disease Control and Prevention, and International Society of Travel Medicine.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23182931     DOI: 10.1016/S1473-3099(12)70291-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  14 in total

1.  Business travel-associated illness: a GeoSentinel analysis.

Authors:  Lin H Chen; Karin Leder; Kira A Barbre; Patricia Schlagenhauf; Michael Libman; Jay Keystone; Marc Mendelson; Philippe Gautret; Eli Schwartz; Marc Shaw; Sue MacDonald; Anne McCarthy; Bradley A Connor; Douglas H Esposito; Davidson Hamer; Mary E Wilson
Journal:  J Travel Med       Date:  2018-01-01       Impact factor: 8.490

2.  Summary of the Statement on International Travellers Who Intend to Visit Friends and Relatives.

Authors:  J Brophy
Journal:  Can Commun Dis Rep       Date:  2015-05-07

3.  Assessment of sex-related behaviours, human immunodeficiency virus (HIV) knowledge and sexually transmitted infections (STIs) among men of reproductive age in Cameroon.

Authors:  Abayomi Samuel Oyekale
Journal:  Int J Environ Res Public Health       Date:  2014-12-09       Impact factor: 3.390

4.  Evaluation of a programme for 'Rapid Assessment of Febrile Travelers' (RAFT): a clinic-based quality improvement initiative.

Authors:  Farah Jazuli; Terence Lynd; Jordan Mah; Michael Klowak; Dale Jechel; Stefanie Klowak; Howard Ovens; Sam Sabbah; Andrea K Boggild
Journal:  BMJ Open       Date:  2016-07-29       Impact factor: 2.692

Review 5.  HIV, Other Blood-Borne Viruses and Sexually Transmitted Infections amongst Expatriates and Travellers to Low- and Middle-Income Countries: A Systematic Review.

Authors:  Gemma Crawford; Roanna Lobo; Graham Brown; Chloe Macri; Hannah Smith; Bruce Maycock
Journal:  Int J Environ Res Public Health       Date:  2016-12-16       Impact factor: 3.390

6.  The role of mobility in sexual risk behaviour and HIV acquisition among sub-Saharan African migrants residing in two European cities.

Authors:  Sónia Dias; Ana Gama; Jasna Loos; Luis Roxo; Daniel Simões; Christiana Nöstlinger
Journal:  PLoS One       Date:  2020-02-05       Impact factor: 3.240

7.  Regional variation in travel-related illness acquired in Africa, March 1997-May 2011.

Authors:  Marc Mendelson; Pauline V Han; Peter Vincent; Frank von Sonnenburg; Jakob P Cramer; Louis Loutan; Kevin C Kain; Philippe Parola; Stefan Hagmann; Effrossyni Gkrania-Klotsas; Mark Sotir; Patricia Schlagenhauf
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

Review 8.  Are you PEPped and PrEPped for travel? Risk mitigation of HIV infection for travelers.

Authors:  D M Brett-Major; P T Scott; T A Crowell; C S Polyak; K Modjarrad; M L Robb; D L Blazes
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-11-28

9.  Travel-related infections in mainland China, 2014-16: an active surveillance study.

Authors:  Li-Qun Fang; Yu Sun; Guo-Ping Zhao; Li-Juan Liu; Zhe-Jun Jiang; Zheng-Wei Fan; Jing-Xue Wang; Yang Ji; Mai-Juan Ma; Juan Teng; Yan Zhu; Ping Yu; Kai Li; Ying-Jie Tian; Wu-Chun Cao
Journal:  Lancet Public Health       Date:  2018-07-20

10.  Illness in travelers returned from Brazil: the GeoSentinel experience and implications for the 2014 FIFA World Cup and the 2016 Summer Olympics.

Authors:  Mary E Wilson; Lin H Chen; Pauline V Han; Jay S Keystone; Jakob P Cramer; Aluisio Segurado; DeVon Hale; Mogens Jensenius; Eli Schwartz; Frank von Sonnenburg; Karin Leder
Journal:  Clin Infect Dis       Date:  2014-02-28       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.